N/A
Completed N=78
HIV-Related Stigma Intervention for Malaysian Clinicians
Source: ClinicalTrials.gov NCT05597787 ↗Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcomePrimary: Acceptability of Intervention — 4.22; 4.72; 4.45 score on a scale
Summary
Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Intervention |
4.22; 4.72; 4.45 | — |
| PRIMARY Feasibility of Intervention |
4.22; 4.62; 4.32 | — |
| PRIMARY Stigma Reduction: Prejudice |
29.13; 23.28; 32.07 | — |
| PRIMARY Stigma Reduction: Stereotypes |
2.55; 2.01; 2.32 | — |
| PRIMARY Stigma Reduction: Discrimination |
4.44; 4.67; 4.64 | — |
| SECONDARY HIV Prevention Procedures: HIV Testing |
21.54; 2.65; 10.46 | — |
| SECONDARY HIV Prevention Procedures: PrEP Prescriptions |
2.04; 0.07; 0.11 | — |
Eligibility Criteria
Inclusion Criteria
- practicing general practitioner or family medicine specialist in Malaysia
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT05597787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.